{"id":"https://openalex.org/W4375855674","doi":"https://doi.org/10.1210/clinem/dgad249","title":"Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS","display_name":"Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS","publication_year":2023,"publication_date":"2023-05-07","ids":{"openalex":"https://openalex.org/W4375855674","doi":"https://doi.org/10.1210/clinem/dgad249","pmid":"https://pubmed.ncbi.nlm.nih.gov/37149821","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10584001"},"language":"en","primary_location":{"id":"doi:10.1210/clinem/dgad249","doi":"https://doi.org/10.1210/clinem/dgad249","is_oa":true,"landing_page_url":"https://doi.org/10.1210/clinem/dgad249","pdf_url":"https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgad249/50399752/dgad249.pdf","source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgad249/50399752/dgad249.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029266453","display_name":"Angel N. Borisov","orcid":"https://orcid.org/0000-0002-7872-0118","observed_orcids":["https://orcid.org/0000-0002-7872-0118"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Angel N Borisov","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, University Center for Gastrointestinal and Liver Diseases , CH-4031 Basel , Switzerland","Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel , 4031 Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-7872-0118","affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, University Center for Gastrointestinal and Liver Diseases , CH-4031 Basel , Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel , 4031 Basel , Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057116885","display_name":"Alexander Kutz","orcid":"https://orcid.org/0000-0002-7549-5648","observed_orcids":["https://orcid.org/0000-0002-7549-5648"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210161075","display_name":"Kantonsspital Aarau","ror":"https://ror.org/056tb3809","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210161075"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Alexander Kutz","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, University Department of Medicine , Kantonsspital Aarau, 5001 Aarau , Switzerland","Division of General and Emergency Medicine, University Department of Medicine , Kantonsspital Aarau, 5001 Aarau , Switzerland","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA"],"raw_orcid":"https://orcid.org/0000-0002-7549-5648","affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, University Department of Medicine , Kantonsspital Aarau, 5001 Aarau , Switzerland","institution_ids":["https://openalex.org/I4210161075"]},{"raw_affiliation_string":"Division of General and Emergency Medicine, University Department of Medicine , Kantonsspital Aarau, 5001 Aarau , Switzerland","institution_ids":["https://openalex.org/I4210161075"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011844380","display_name":"Emanuel Christ","orcid":"https://orcid.org/0000-0002-5604-4606","observed_orcids":["https://orcid.org/0000-0002-5604-4606"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Emanuel R Christ","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel , 4031 Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-5604-4606","affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel , 4031 Basel , Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021281577","display_name":"Markus Hermann Heim","orcid":"https://orcid.org/0000-0002-7523-4894","observed_orcids":["https://orcid.org/0000-0002-7523-4894"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Markus H Heim","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, University Center for Gastrointestinal and Liver Diseases , CH-4031 Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-7523-4894","affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, University Center for Gastrointestinal and Liver Diseases , CH-4031 Basel , Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059364386","display_name":"Fahim Ebrahimi","orcid":"https://orcid.org/0000-0001-5862-966X","observed_orcids":["https://orcid.org/0000-0001-5862-966X"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["CH","SE"],"is_corresponding":true,"raw_author_name":"Fahim Ebrahimi","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, University Center for Gastrointestinal and Liver Diseases , CH-4031 Basel , Switzerland","Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , 17165 Stockholm , Sweden","Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel , 4031 Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-5862-966X","affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, University Center for Gastrointestinal and Liver Diseases , CH-4031 Basel , Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , 17165 Stockholm , Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel , 4031 Basel , Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5059364386"],"corresponding_institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264","https://openalex.org/I28166907"],"apc_list":{"value":3400,"currency":"USD","value_usd":3400},"apc_paid":{"value":3400,"currency":"USD","value_usd":3400},"fwci":4.9595,"has_fulltext":true,"cited_by_count":39,"citation_normalized_percentile":{"value":0.97076956,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"108","issue":"11","first_page":"2940","last_page":"2949"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.09950000047683716,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9160000085830688},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/alanine-aminotransferase","display_name":"alanine aminotransferase","score":0.8840000033378601},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.843999981880188},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.8330000042915344},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7870000004768372},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7799999713897705},{"id":"https://openalex.org/keywords/canvas-trial","display_name":"CANVAS trial","score":0.7630000114440918},{"id":"https://openalex.org/keywords/noninvasive-fibrosis-assessment","display_name":"noninvasive fibrosis assessment","score":0.7239999771118164},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.3880000114440918},{"id":"https://openalex.org/keywords/liver-related-outcomes","display_name":"liver-related outcomes","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.9538470506668091},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8501284718513489},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7163501977920532},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.6644998788833618},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6407809257507324},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.570565938949585},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5374316573143005},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5328488945960999},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5176770687103271},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.48551154136657715},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4815985858440399},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3931979835033417},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.36830228567123413},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.19702544808387756},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10289910435676575},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005355","descriptor_name":"Fibrosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1210/clinem/dgad249","doi":"https://doi.org/10.1210/clinem/dgad249","is_oa":true,"landing_page_url":"https://doi.org/10.1210/clinem/dgad249","pdf_url":"https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgad249/50399752/dgad249.pdf","source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10584001","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10584001","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Endocrinol Metab","raw_type":"Text"},{"id":"pmid:37149821","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37149821","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1210/clinem/dgad249","doi":"https://doi.org/10.1210/clinem/dgad249","is_oa":true,"landing_page_url":"https://doi.org/10.1210/clinem/dgad249","pdf_url":"https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgad249/50399752/dgad249.pdf","source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4144002615","display_name":"Effectiveness and safety of SGLT-2 inhibitors and GLP-1 receptor agonists in older patients with type 2 diabetes - A comparative effectiveness study proposal using real-world data","funder_award_id":"194479","funder_id":"https://openalex.org/F4320320924","funder_display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung"},{"id":"https://openalex.org/G7235791371","display_name":"Characterization of Determinants of Disease Occurrence, Progression and Adverse Clinical Outcomes in Metabolic-Associated Fatty Liver Disease - A Population-Based Derivation Study and Prospective Validation Study","funder_award_id":"210866","funder_id":"https://openalex.org/F4320320924","funder_display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320308380","display_name":"Yale University","ror":"https://ror.org/03v76x132"},{"id":"https://openalex.org/F4320320924","display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","ror":"https://ror.org/00yjd3n13"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4375855674.pdf","grobid_xml":"https://content.openalex.org/works/W4375855674.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1997865776","https://openalex.org/W2021000378","https://openalex.org/W2025512398","https://openalex.org/W2039933259","https://openalex.org/W2059613020","https://openalex.org/W2059630954","https://openalex.org/W2064387090","https://openalex.org/W2112496618","https://openalex.org/W2136057321","https://openalex.org/W2156116850","https://openalex.org/W2161883681","https://openalex.org/W2255641665","https://openalex.org/W2410373838","https://openalex.org/W2510230324","https://openalex.org/W2610920150","https://openalex.org/W2617012806","https://openalex.org/W2626446274","https://openalex.org/W2756408217","https://openalex.org/W2772777089","https://openalex.org/W2774655822","https://openalex.org/W2892498615","https://openalex.org/W2900413769","https://openalex.org/W2901946789","https://openalex.org/W2906364339","https://openalex.org/W2917128826","https://openalex.org/W2922345412","https://openalex.org/W2938096756","https://openalex.org/W2965882554","https://openalex.org/W2989454232","https://openalex.org/W3003593800","https://openalex.org/W3004644667","https://openalex.org/W3027707577","https://openalex.org/W3092264591","https://openalex.org/W3094737477","https://openalex.org/W3095535267","https://openalex.org/W3119009002","https://openalex.org/W3125674226","https://openalex.org/W3126379854","https://openalex.org/W3129584656","https://openalex.org/W3162773903","https://openalex.org/W3197051840","https://openalex.org/W3206948891","https://openalex.org/W3208671080","https://openalex.org/W3212896804","https://openalex.org/W4223422078","https://openalex.org/W4281708639","https://openalex.org/W4283804489","https://openalex.org/W4288067825","https://openalex.org/W6925353530"],"related_works":["https://openalex.org/W7168153901","https://openalex.org/W2810610880","https://openalex.org/W2900924712","https://openalex.org/W6990708198","https://openalex.org/W2982602066","https://openalex.org/W2902717147","https://openalex.org/W2765826121","https://openalex.org/W7169713182","https://openalex.org/W7166184587","https://openalex.org/W3162141249"],"abstract_inverted_index":{"CONTEXT:":[0],"Metabolic":[1],"dysfunction-associated":[2],"fatty":[3],"liver":[4,184,269,277],"disease":[5],"(MAFLD)":[6],"is":[7,20],"highly":[8],"prevalent":[9],"among":[10],"patients":[11,40,59,89,145,196,257],"with":[12,41,60,90,148,202,240,245,258,261],"type":[13],"2":[14,28,76],"diabetes":[15,162],"mellitus":[16],"(T2DM);":[17],"however,":[18],"there":[19],"still":[21],"no":[22],"approved":[23],"pharmacological":[24],"treatment.":[25],"Sodium-glucose":[26],"cotransporter":[27],"(SGLT-2)":[29],"inhibitors":[30],"have":[31],"been":[32],"suggested":[33],"to":[34,46,99,175,217,243],"beneficially":[35,275],"modify":[36],"liver-related":[37,56],"outcomes":[38,57],"in":[39,58,130,193,200,219,238,266,268],"diabetes.":[42],"OBJECTIVE:":[43],"We":[44,68],"aimed":[45],"investigate":[47],"the":[48,51],"effects":[49],"of":[50,75,113,115,123,133,138,152,161,195,223,231],"SGLT-2":[52],"inhibitor":[53],"canagliflozin":[54,102,198,241,262],"on":[55],"advanced":[61],"T2DM":[62,91],"and":[63,84,92,135,179,199,271,273],"high":[64,93],"cardiovascular":[65,94],"risk.":[66],"METHODS:":[67],"performed":[69],"a":[70,111,149],"secondary":[71],"post":[72],"hoc":[73],"analysis":[74],"large":[77],"double-blind":[78],"randomized":[79,98],"controlled":[80],"trials,":[81],"CANVAS":[82],"(NCT01032629)":[83],"CANVAS-R":[85],"(NCT01989754),":[86],"which":[87],"included":[88,128],"risk":[95],"who":[96],"were":[97,146],"receive":[100],"either":[101],"or":[103,121],"placebo":[104,203,246,264],"once":[105],"daily.":[106],"The":[107,188],"primary":[108,189],"endpoint":[109,191],"was":[110,236],"composite":[112,190],"improvement":[114],"alanine":[116],"aminotransferase":[117],"(ALT)":[118],"levels":[119],">30%":[120],"normalization":[122],"ALT":[124],"levels.":[125],"Secondary":[126],"endpoints":[127],"change":[129],"noninvasive":[131,221],"tests":[132,222],"fibrosis":[134,224],"weight":[136,229],"reduction":[137,230],">10%.":[139],"RESULTS:":[140],"In":[141,256],"total,":[142],"10":[143],"131":[144],"included,":[147],"median":[150],"follow-up":[151],"2.4":[153],"years":[154],"(mean":[155],"age":[156],"62":[157],"years;":[158,164],"mean":[159],"duration":[160],"13.5":[163],"64.2%":[165],"male).":[166],"Of":[167],"those":[168],"patients,":[169],"8967":[170],"(88.5%)":[171],"had":[172],"MAFLD":[173],"according":[174],"hepatic":[176],"steatosis":[177],"index":[178],"2599":[180],"(25.7%)":[181],"exhibited":[182],"elevated":[183],"biochemistry":[185,270],"at":[186],"baseline.":[187],"occurred":[192],"35.2%":[194],"receiving":[197],"26.4%":[201],"(adjusted":[204],"odds":[205],"ratio":[206],"[aOR]":[207],"1.51;":[208],"95%":[209,249],"CI,":[210,250],"1.38-1.64;":[211],"P":[212,252],"<":[213,253],".001).":[214,254],"Canagliflozin":[215],"led":[216],"improvements":[218,267],"some":[220],"(NFS,":[225],"APRI,":[226],"FNI).":[227],"Significant":[228],">10%":[232],"(within":[233],"6":[234],"years)":[235],"achieved":[237],"12.7%":[239],"compared":[242],"4.1%":[244],"(aOR":[247],"3.45;":[248],"2.91-4.10;":[251],"CONCLUSION:":[255],"T2DM,":[259],"treatment":[260],"vs":[263],"resulted":[265],"metabolism":[272],"might":[274],"affect":[276],"fibrosis.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-05-10T00:00:00"}